Centiva Capital’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Centiva Capital’s Portfolio SWAV Stock Details SWAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-5,000	Closed	-$1.63M	–	2608
2024 Q1	$1.63M	Buy	+5,000	New	+$1.23M	0.04%	418

Other funds holding SWAV

Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return

UWS

Unique Wealth Strategies Burr Ridge, Illinois $275M AUM 29.58% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Centiva Capital's SWAV Position: Q2 2024 in Review

Centiva Capital sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 3,500 shares — an estimated $1.14M sold.

Centiva Capital first reported a position in SWAV in Q2 2021 and held it in 5 quarters. The position peaked at $7.26M in Q2 2023. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

Centiva Capital reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Centiva Capital sold 3,500 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $1.14M.
Centiva Capital first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2021 and held it in 5 quarters.
Centiva Capital's Shockwave Medical, Inc. Common Stock position peaked at $7.26M in Q2 2023.
7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Centiva Capital's 13F filing for Q2 2024, filed 14 Aug 2024.